Activist Fund Manager Ups Stake in Amag Pharma to Stop Merger With Allos – TheStreet.com


Activist Fund Manager Ups Stake in Amag Pharma to Stop Merger With Allos
TheStreet.com
LEXINGTON, Mass. (TheStreet) –Hedge fund manager Martin Shkreli has taken a 5.8% ownership stake in Amag Pharmaceuticals(AMAG), an escalation of his effort to wrest control of the struggling drug maker and
Allos Therapeutics Continues to Work Toward Completion of Merger with AMAG MarketWatch (press release)

all 13 news articles »

Pharmaceuticals – Google News